A
Anvajo
A Dresden-based technology company that develops, manufactures and sells innovative solutions for the analysis of liquids
About Anvajo
Anvajo is a pioneering developer and manufacturer of point of care solutions for laboratory diagnostic testing of liquids. The company's flagship product, the fluidlab, is a compact, handheld device that combines microscopy and spectrometry to provide rapid, accurate, and quantitative analysis of various fluids, including blood, urine, sperm, and water. This innovative platform is designed to be easy to use, portable, and cost-effective, making it ideal for field usage in structurally underdeveloped regions. Anvajo primarily serves healthcare providers, laboratories, and research institutions, offering them a reliable and efficient tool for fluid diagnostics. The company's business model revolves around the sale of the fluidlab devices and associated consumables, generating revenue through direct sales and partnerships. By addressing the need for accessible and precise diagnostic tools, Anvajo is positioned in the growing market of point of care testing technologies.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2016
- Headquarters
- Dresden, Germany
- Employees
- 50
- Open positions
- 1
- Dealroom signal
- 67.9/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Testing, Risk Management, Biotechnology, EIT Health, Hard Tech, Woman Founder, EIT Ecosystem
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEED✓Equity / VC | Dec 2024 | — | — | Die BrückenKöpfe · Bold Ventures · FSF Beteiligungs · Medice | — |
| EARLY VC✓Equity / VC | Oct 2022 | $19M | $78M | Think.Health · Medice · Johnson Venture Partners · Elber Beteiligungen | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Anvajo is 3.3K monthly website visits, up 4025% over the last three months. Anvajo's team grew 0% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed5 investors entered at this stage
- DBDie BrückenKöpfe
Bold Ventures- FBFSF Beteiligungs
Minoa- JAJVL Ventures Anvajo
Series A4 investors entered at this stage
Think.Health
Medice
Johnson Venture Partners- EBElber Beteiligungen
Other known investors4 additional known investors
EIT Health
German Accelerator- SCSanno Capital
Seedcamp
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Anvajo on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Anvajo’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.